ArticleFrontiers in oncology2022
Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer.
Cynthia Ménard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it